Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 04
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.03%
|
$11,461
$1.64 P/Share
|
|
Nov 02
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.2%
|
$618,894
$54.72 P/Share
|
|
Nov 02
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.03%
|
$11,461
$1.64 P/Share
|
|
Oct 25
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.75%
|
$718,608
$44.45 P/Share
|
|
Oct 25
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.79%
|
$16,332
$1.64 P/Share
|
|
Oct 25
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
2,371
-1.87%
|
$104,324
$44.62 P/Share
|
|
Oct 20
2021
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
272
-1.37%
|
$11,424
$42.34 P/Share
|
|
Oct 20
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
399
-1.28%
|
$16,758
$42.34 P/Share
|
|
Oct 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$410,000
$41.97 P/Share
|
|
Oct 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Oct 18
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$410,000
$41.34 P/Share
|
|
Oct 18
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Oct 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.35%
|
$246,400
$40.76 P/Share
|
|
Oct 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
|
Oct 14
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
7,055
-4.24%
|
$275,145
$39.91 P/Share
|
|
Oct 14
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
|
Oct 14
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
1,221
-0.95%
|
$47,619
$39.97 P/Share
|
|
Oct 14
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
3,215
-1.22%
|
$125,385
$39.97 P/Share
|
|
Oct 14
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
1,082
-1.51%
|
$42,198
$39.97 P/Share
|
|
Oct 14
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,273
-0.61%
|
$49,647
$39.97 P/Share
|
|
Oct 11
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
245
-0.78%
|
$9,310
$38.22 P/Share
|
|
Oct 07
2021
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
3,250
-9.88%
|
$130,000
$40.11 P/Share
|
|
Oct 07
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.15%
|
$458,440
$40.55 P/Share
|
|
Oct 07
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.99%
|
$11,461
$1.64 P/Share
|
|
Oct 05
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.15%
|
$458,440
$40.63 P/Share
|
|
Oct 05
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.99%
|
$11,461
$1.64 P/Share
|
|
Oct 01
2021
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,938
+50.0%
|
-
|
|
Sep 28
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
505
-0.64%
|
$21,715
$43.12 P/Share
|
|
Sep 28
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
689
-0.54%
|
$29,627
$43.12 P/Share
|
|
Sep 28
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
907
-0.34%
|
$39,001
$43.12 P/Share
|
|
Sep 28
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
610
-0.84%
|
$26,230
$43.12 P/Share
|
|
Sep 28
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
719
-0.34%
|
$30,917
$43.12 P/Share
|
|
Sep 27
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.4%
|
$718,608
$44.66 P/Share
|
|
Sep 27
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.54%
|
$16,332
$1.64 P/Share
|
|
Sep 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.56%
|
$460,000
$46.99 P/Share
|
|
Sep 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Sep 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.56%
|
$460,000
$46.89 P/Share
|
|
Sep 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Sep 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$283,360
$46.1 P/Share
|
|
Sep 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Sep 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$301,840
$49.01 P/Share
|
|
Sep 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Sep 09
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.14%
|
$595,972
$52.59 P/Share
|
|
Sep 09
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.97%
|
$11,461
$1.64 P/Share
|
|
Sep 07
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.14%
|
$595,972
$52.5 P/Share
|
|
Sep 07
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.97%
|
$11,461
$1.64 P/Share
|
|
Sep 01
2021
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
126,185
+1.64%
|
-
|
|
Aug 27
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
399
-0.19%
|
$22,743
$57.26 P/Share
|
|
Aug 26
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
848
-0.32%
|
$48,336
$57.26 P/Share
|
|
Aug 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
325
-0.45%
|
$18,525
$57.26 P/Share
|